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Background
• In the United States, 1.7 million new cases of
•
•

•

•

cancer were diagnosed in 2018 and the disease
was fatal for 600,000 people (CDC, 2021).
Each year, about 650,000 cancer patients receive
chemotherapy in an outpatient oncology clinic in
the United States (CDC, 2021).
Approximately 25% of 400 novel chemotherapy
agents in development are oral agents with
multiple-day dosing regimens (Wong, 2016). Many
patients do not take these drugs as prescribed.
The World Health Organization lists factors
affecting adherence to therapies as socioeconomic,
health, condition, therapy, and patient-related
factors (WHO, 2003).
With increasing use of prescribed oral chemo drugs
for treating patients with cancer, the American
Society of Clinical Oncology (ASCO) and Oncology
Nursing Society (ONS) updated chemotherapy
standards for safe administration to include oral
agents (Neuss et al., 2016). These standards
include patient education, toxicity assessment.

Synthesis of Evidence
• Nurses completed a questionnaire regarding oral
•
•
•

•
•

chemotherapy adherence prior to and postcompletion of education to measure learning.
Patients were instructed to contact their nurse
navigator upon receiving medication from
specialty pharmacy to review directions.
Patients were referred to a financial navigator
with barriers to obtaining medication.
Nurse navigators conducted follow-up 1 week
after initiating oral chemotherapy and continued
weekly during one-month timeline. This included
assessing adherence, symptom management,
toxicities, and potential barriers to treatment.
Patients were monitored with scripted questions,
including Morisky Medication Adherence.
Oral Chemotherapy Safety Patient Education tool
was created and then presented to the Patient
and Family Advisory Council for approval.

Results
• 18 established patients were prescribed oral
•
•
•
•

chemotherapy. Of those patients, 4
experienced a delay in their medication.
Adherence to oral chemotherapy increased
from 70% to 78%.
Two of the 4 patients who were non-adherent
experienced delays in medication delivery
from the same specialty pharmacy.
Significant increase in nursing knowledge of
chemotherapy and adherence resulted from
the education (from 31% to 100%).
During weekly phone calls, patients expressed
appreciation for the nurse’s contact and
coordination of care.
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Figure 2. 78% adherence to oral chemotherapy.

• Comparison: Standard care (lack of consistent
Figure 1. Baseline data: Only 31% of RNs were aware of
patients experiencing delays in treatment. After nursing
education: 100% of RNs demonstrated awareness.

process).

• Outcome: Documented improved patient
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• Nursing education provided regarding oral

adherence, adherence barriers.

• In the first five months of 2021, 21 patients at
Advocate Sherman Hospital Cancer Center were
prescribed oral chemotherapy drugs. Of those
patients, 6 (30%) were found non-adherent. That
resulted in only a 70% adherence rate (15 patients).

• National standards were referenced: The
ASCO/ONS Chemotherapy Administration Safety
Standards for the Safe Administration and
Management of Oral Chemotherapy were used to
align patient tracking and education tools.

•

•
•
•

chemotherapy adherence.
Implementation of nurse navigation workflow
process for providing patient education and
weekly follow up calls, identifying barriers to
adherence.
Daily rounding to discuss patients and their
current regimens and tracking barriers.
Standardized education to patients regarding oral
chemotherapy safety.
This practice has been in place since project
completion September 2021.
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Implications for Practice
• The process to make weekly calls to every patient
prescribed oral chemotherapy will continue to the first
month.
Patient education using the process developed in this
project will continue to be used in the cancer center.
Daily navigation rounding to monitor current patients on oral
chemotherapy and track follow up.
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chemotherapy adherence.
Delays identified at the one insurance-approved specialty
pharmacy have been addressed and will continue to be
monitored by nurse navigators.
No patients involved in the project were admitted to the
hospital due to medication adherence.
Delays at the one insurance-approved specialty pharmacy
were addressed and continue to be monitored by nurse
navigators.
Limitations include short timeframe of project.
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Objective
• Time: One month
• Population: Adult patients, 18 years and older who

Outcomes / Conclusions
• A nurse-driven intervention resulted in improved
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Patients Prescribed Oral Chemo

Patients Delayed in Receiving Medication

Figure 3. Two of the 4 patients who where non-adherent
experienced delays in medication delivery from the same
specialty pharmacy.
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